Key result
Quinapril is an effective and safe ACE inhibitor for the management of hypertension and congestive heart failure, with a positive benefit-risk profile when appropriately monitored for adverse events.
This review highlights that quinapril is an effective and generally safe ACE inhibitor for treating hypertension and heart failure, provided risks like hypotension and angioedema are monitored.
Answers are grounded in this paper and cite their sources.
May support quinapril in hypertension and HF with monitoring; leaves open need for contemporary RCTs versus newer agents.
The purpose of this review is to give the readers an insight about the risks and benefits of 'quinapril', a potent Angiotensin Converting Enzyme Inhibitor (ACEI). Quinapril is a highly effective novel drug indicated for treatment of congestive heart failure and hypertension. Despite of the fact that safety profile is quite well with low incidence of adverse effects, an attempt has been made to minimize the risks and subsequently minimizing the adverse consequences of this competitive inhibitor, thereby increasing the benefits of this enzyme inhibitor in day to day clinical practice.
No takes yet. Share an insight, caveat, or question.
A 2014 study conducted a review in Hypertension and congestive heart failure. Quinapril was evaluated. Quinapril is an effective and safe ACE inhibitor for the management of hypertension and congestive heart failure, with a positive benefit-risk profile when appropriately monitored for adverse events.
Synapse has enriched 10 related papers. Consider them for comparative context: